Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Amgen Inc Stock Surges 3.19% on Analyst Upgrade and Sector Rally

Guavy AI Editorial Team
Instruments
AMGN
Share

Amgen Inc's stock price surged by 3.19% on August 19, driven by positive analyst momentum and a strong sector-wide rally in healthcare equities.

The company's stock was propelled by a high-profile price target upgrade from Argus, which raised its valuation target while reiterating a Buy rating.

Analysts at Argus highlighted robust volume expansion across key commercialized therapies, as well as significant growth potential from newly launched treatments, biosimilars, and pipeline developments.

More on Stocks

Stocks 11m ago

Chevron Ditches Kurdistan Region, Focuses on Southern Iraq Oil Projects

Stocks 11m ago

Chevron-Woodside Asset Swap Sparks Concerns Over Australian Gas Market

Stocks 12m ago

Woodside Eyes Chevron Assets Amid Regulatory Review

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy